297 related articles for article (PubMed ID: 309473)
1. Interaction of platelet membrane receptors with von Willebrand factor, ristocetin, and the Fc region of immunoglobulin G.
Moore A; Ross GD; Nachman RL
J Clin Invest; 1978 Nov; 62(5):1053-60. PubMed ID: 309473
[TBL] [Abstract][Full Text] [Related]
2. Agglutination of formalin-fixed, platelet-type von Willebrand's disease platelets by human von Willebrand factor.
Takahashi H; Shibata A
Thromb Haemost; 1984 Dec; 52(3):267-70. PubMed ID: 6241752
[TBL] [Abstract][Full Text] [Related]
3. Interaction of platelets, von Willebrand factor, and ristocetin during platelet agglutination.
Moake JL; Olson JD; Troll JH; Weinger RS; Peterson DM; Cimo PL
J Lab Clin Med; 1980 Jul; 96(1):168-84. PubMed ID: 6967100
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of von Willebrand factor-induced platelet agglutination by ADP does not result from reduced binding of total von Willebrand factor or its larger multimers.
Zucker MB; Puszkin EG; Sussman II; Mauss EA
J Lab Clin Med; 1990 Sep; 116(3):305-14. PubMed ID: 2401846
[TBL] [Abstract][Full Text] [Related]
5. The effects of ristocetin and von Willebrand factor on platelet electrophoretic mobility.
Coller BS
J Clin Invest; 1978 May; 61(5):1168-75. PubMed ID: 307006
[TBL] [Abstract][Full Text] [Related]
6. A comparative study of the effect of modification of the surface of human platelets on the receptors for aggregated immunoglobulins and for ristocentin-von Willebrand factor.
Pfueller SL; Jenkins CS; Lüscher EF
Biochim Biophys Acta; 1977 Mar; 465(3):614-26. PubMed ID: 319830
[TBL] [Abstract][Full Text] [Related]
7. Role of platelet membrane glycoproteins Ib/IX and IIb/IIIa, and of platelet alpha-granule proteins in platelet aggregation induced by human osteosarcoma cells.
Clezardin P; Drouin J; Morel-Kopp MC; Hanss M; Kehrel B; Serre CM; Kaplan C; Delmas PD
Cancer Res; 1993 Oct; 53(19):4695-700. PubMed ID: 7691402
[TBL] [Abstract][Full Text] [Related]
8. Immunoinhibition of ristocetin-induced platelet aggregation.
Nachman RL; Jaffe EA; Weksler BB
J Clin Invest; 1977 Jan; 59(1):143-8. PubMed ID: 299747
[TBL] [Abstract][Full Text] [Related]
9. Mapping and functional studies of two alloantibodies developed in patients with type 3 von Willebrand disease.
Tout H; Obert B; Houllier A; Fressinaud E; Rothschild C; Meyer D; Girma JP
Thromb Haemost; 2000 Feb; 83(2):274-81. PubMed ID: 10739386
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of ristocetin-induced platelet agglutination by vancomycin.
Moake JL; Cimo PL; Peterson DM; Roper P; Natelson EA
Blood; 1977 Sep; 50(3):397-406. PubMed ID: 301760
[TBL] [Abstract][Full Text] [Related]
11. Asialo von Willebrand factor interactions with platelets. Interdependence of glycoproteins Ib and IIb/IIIa for binding and aggregation.
Grainick HR; Williams SB; Coller BS
J Clin Invest; 1985 Jan; 75(1):19-25. PubMed ID: 2981249
[TBL] [Abstract][Full Text] [Related]
12. Membrane fluidity and platelet aggregation: dibucaine permits ristocetin-induced platelet aggregation with low-molecular-weight von Willebrand multimers.
Gjønnaess E; Solum NO; Brosstad F
Blood Coagul Fibrinolysis; 1992 Aug; 3(4):395-405. PubMed ID: 1420815
[TBL] [Abstract][Full Text] [Related]
13. Staphylococci-induced human platelet injury mediated by protein A and immunoglobulin G Fc fragment receptor.
Hawiger J; Steckley S; Hammond D; Cheng C; Timmons S; Glick AD; Des Prez RM
J Clin Invest; 1979 Oct; 64(4):931-7. PubMed ID: 479376
[TBL] [Abstract][Full Text] [Related]
14. Interactions of purified rat factor VIII/von Willebrand factor with rat and human platelets--effect of albumin and ristocetin.
Dejana E; Furlan M; Barbieri B; Donati MB; Beck EA
Thromb Haemost; 1984 Aug; 52(1):57-9. PubMed ID: 6437011
[TBL] [Abstract][Full Text] [Related]
15. Von Willebrand's disease with spontaneous platelet aggregation induced by an abnormal plasma von Willebrand factor.
Grainick HR; Williams SB; McKeown LP; Rick ME; Maisonneuve P; Jenneau C; Sultan Y
J Clin Invest; 1985 Oct; 76(4):1522-9. PubMed ID: 2932469
[TBL] [Abstract][Full Text] [Related]
16. Agglutination of platelet-type von Willebrand's disease platelets by bovine von Willebrand factor.
Takahashi H; Shibata A
Thromb Haemost; 1985 Apr; 53(2):204-7. PubMed ID: 2992113
[TBL] [Abstract][Full Text] [Related]
17. Platelet-bound ristocetin aggregation factor in normal subjects and patients with von Willebrand's disease.
Green D; Potter EV
J Lab Clin Med; 1976 Jun; 87(6):976-86. PubMed ID: 778313
[TBL] [Abstract][Full Text] [Related]
18. Platelet membrane glycoproteins implicated in ristocetin-induced aggregation. Studies of the proteins on platelets from patients with Bernard-Soulier syndrome and von Willebrand's disease.
Jenkins CS; Phillips DR; Clemetson KJ; Meyer D; Larrieu MJ; Lüscher EF
J Clin Invest; 1976 Jan; 57(1):112-24. PubMed ID: 1081991
[TBL] [Abstract][Full Text] [Related]
19. Ristocetin and botrocetin involve two distinct domains of von Willebrand factor for binding to platelet membrane glycoprotein Ib.
Girma JP; Takahashi Y; Yoshioka A; Diaz J; Meyer D
Thromb Haemost; 1990 Oct; 64(2):326-32. PubMed ID: 1702906
[TBL] [Abstract][Full Text] [Related]
20. Platelet-binding of the von Willebrand factor.
Green D; Muller HP
Thromb Haemost; 1978 Jun; 39(3):689-94. PubMed ID: 309191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
